Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-01
Description
The present notice is for the conclusion of agreements with pharmaceutical companies in accordance with § 130a, paragraph 8, sentence 1 SGB V. The invitation to participate is directed only at pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs in the sense of § 4, paragraph 18 of the Medicinal Products Act. This is not an Open Procedure in accordance with § 15 VgV in conjunction with § 119, paragraph 3 GWB, but a publication of the invitation to conclude/join discount contracts with conditions, including the amount of the discount, that are fixed and non-negotiable for all participants. An unlimited number of pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs in the sense of § 4, paragraph 18 of the Medicinal Products Act can become contracting parties.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Medical equipments, pharmaceuticals and personal care products – Dynamisches Beschaffungssystem Arzneimittel
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyMedical equipments, pharmaceuticals and personal care productsPharmaceutical productsNo deadline givenPublished on Oct 27, 2026
Germany – Medical breathing devices – Beatmungsgeräte mit Zubehör
Land Hessen, vertreten durch das Hessische Competence Center -Beschaffungen-GermanyMedical breathing devicesDeadline in 14 daysPublished on Oct 27, 2026
Germany – Medical breathing devices – Beschaffung von 12 Beatmungsgeräten für die interdisziplinäre operative Intensivstation
Krankenhausgesellschaft St. Vincenz mbH (St. Vincenz Krankenhaus Limburg)GermanyMedical breathing devicesNo deadline givenPublished on Oct 27, 2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tocilizumab (ATC-Code nach WHO: L04AC07)
AOK PLUS - Die Gesundheitskasse für Sachsen und ThüringenGermanyPharmaceutical productsDeadline in 642 daysPublished on Oct 27, 2026